Avalo Therapeutics
AVTX
AVTX
55 hedge funds and large institutions have $127M invested in Avalo Therapeutics in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+12
Holders Change %
+27.91%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
19
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$14.8M |
| 2 |
AC
Armistice Capital
New York
|
+$4.56M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.04M |
| 4 |
SCM
Sio Capital Management
New York
|
+$2.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.63M |
